- Poland
- /
- Healthtech
- /
- WSE:SNT
Synektik Spólka Akcyjna's (WSE:SNT) 25% Price Boost Is Out Of Tune With Earnings
Synektik Spólka Akcyjna (WSE:SNT) shares have had a really impressive month, gaining 25% after a shaky period beforehand. The last month tops off a massive increase of 141% in the last year.
After such a large jump in price, Synektik Spólka Akcyjna may be sending bearish signals at the moment with its price-to-earnings (or "P/E") ratio of 17.5x, since almost half of all companies in Poland have P/E ratios under 11x and even P/E's lower than 7x are not unusual. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's as high as it is.
With earnings growth that's superior to most other companies of late, Synektik Spólka Akcyjna has been doing relatively well. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.
View our latest analysis for Synektik Spólka Akcyjna
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Synektik Spólka Akcyjna.How Is Synektik Spólka Akcyjna's Growth Trending?
In order to justify its P/E ratio, Synektik Spólka Akcyjna would need to produce impressive growth in excess of the market.
Retrospectively, the last year delivered an exceptional 104% gain to the company's bottom line. Pleasingly, EPS has also lifted 885% in aggregate from three years ago, thanks to the last 12 months of growth. Therefore, it's fair to say the earnings growth recently has been superb for the company.
Turning to the outlook, the next year should bring diminished returns, with earnings decreasing 3.9% as estimated by the two analysts watching the company. That's not great when the rest of the market is expected to grow by 13%.
With this information, we find it concerning that Synektik Spólka Akcyjna is trading at a P/E higher than the market. It seems most investors are hoping for a turnaround in the company's business prospects, but the analyst cohort is not so confident this will happen. Only the boldest would assume these prices are sustainable as these declining earnings are likely to weigh heavily on the share price eventually.
The Key Takeaway
Synektik Spólka Akcyjna shares have received a push in the right direction, but its P/E is elevated too. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
We've established that Synektik Spólka Akcyjna currently trades on a much higher than expected P/E for a company whose earnings are forecast to decline. Right now we are increasingly uncomfortable with the high P/E as the predicted future earnings are highly unlikely to support such positive sentiment for long. This places shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.
The company's balance sheet is another key area for risk analysis. Take a look at our free balance sheet analysis for Synektik Spólka Akcyjna with six simple checks on some of these key factors.
Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:SNT
Synektik Spólka Akcyjna
Provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.
Outstanding track record with flawless balance sheet.